An artificial intelligence algorithm for automated blastocyst morphometric parameters demonstrates a positive association with implantation potential.

Journal: Scientific reports
PMID:

Abstract

Blastocyst selection is primarily based on morphological scoring systems and morphokinetic data. These methods involve subjective grading and time-consuming techniques. Artificial intelligence allows for objective and quick blastocyst selection. In this study, 608 blastocysts were selected for transfer using morphokinetics and Gardner criteria. Retrospectively, morphometric parameters of blastocyst size, inner cell mass (ICM) size, ICM-to-blastocyst size ratio, and ICM shape were automatically measured by a semantic segmentation neural network model. The model was trained on 1506 videos with 102 videos for validation with no overlap between the ICM and trophectoderm models. Univariable logistic analysis found blastocyst size and ICM-to-blastocyst size ratio to be significantly associated with implantation potential. Multivariable regression analysis, adjusted for woman age, found blastocyst size to be significantly associated with implantation potential. The odds of implantation increased by 1.74 for embryos with a blastocyst size greater than the mean (147 ± 19.1 μm). The performance of the algorithm was represented by an area under the curve of 0.70 (p < 0.01). In conclusion, this study supports the association of a large blastocyst size with higher implantation potential and suggests that automatically measured blastocyst morphometrics can be used as a precise, consistent, and time-saving tool for improving blastocyst selection.

Authors

  • Yael Fruchter-Goldmeier
    The Medical School for International Health and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Ben Kantor
    Fairtilty Ltd, Tel Aviv, Israel.
  • Assaf Ben-Meir
    Fertility and IVF Unit, Department of Obstetrics and Gynecology, The Hebrew University Hadassah Medical Center, Jerusalem, Israel.
  • Tamar Wainstock
    School of Public Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Itay Erlich
    The Alexander Grass Center for Bioengineering, School of Computer Science and Engineering, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Eliahu Levitas
    The Medical School for International Health and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Yoel Shufaro
    Infertility and IVF Unit, Beilinson Women's Hospital, Rabin Medical Center, Petach-Tikva, Israel.
  • Onit Sapir
    Infertility and IVF Unit, Beilinson Women's Hospital, Rabin Medical Center, Petach-Tikva, Israel.
  • Iris Har-Vardi
    Fairtilty Ltd, Tel Aviv, Israel.